AURORA, Colo., June 13, 2023 /PRNewswire/ — Foresight Diagnostics, the leader in ultrasensitive minimal residual disease (MRD) detection technology, announced today that Mark Roschewski, MD, of the National Cancer Institute, part of the National Institutes of Health, will present pooled…
Related Articles
Building a Research Career in Colorado: Insights from an Inaugural Boettcher Investigator
Colorado’s strength in biomedical research grows from the work of early-career investigators who ask big questions and pursue them with rigor. For sixteen years, Boettcher Foundation and Colorado BioScience Association have partnered to support that […]
Amedisys and nVoq Present Outcomes from Speech Recognition Study at PALTC23 Conference
BOULDER, Colo., March 9, 2023 /PRNewswire/ — nVoq Incorporated, the in-home healthcare industry’s leading provider of HIPAA compliant speech recognition solutions, collaborated with Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, and […]
Ignite Counseling Colorado Announces Exciting Move to Expanded Healing Space
WESTMINSTER, Colo., March 13, 2024 /PRNewswire/ — Ignite Counseling Colorado, a leading provider of counseling services in the Denver metro area, is thrilled to announce its relocation to a new, expanded healing space strategically located […]
